Centre for Infection, Department of Cellular and Molecular Medicine, St. George's University of London, London, United Kingdom.
Clin Microbiol Rev. 2010 Jan;23(1):74-98. doi: 10.1128/CMR.00032-09.
In global terms, respiratory viral infection is a major cause of morbidity and mortality. Infancy, in particular, is a time of increased disease susceptibility and severity. Early-life viral infection causes acute illness and can be associated with the development of wheezing and asthma in later life. The most commonly detected viruses are respiratory syncytial virus (RSV), rhinovirus (RV), and influenza virus. In this review we explore the complete picture from epidemiology and virology to clinical impact and immunology. Three striking aspects emerge. The first is the degree of similarity: although the infecting viruses are all different, the clinical outcome, viral evasion strategies, immune response, and long-term sequelae share many common features. The second is the interplay between the infant immune system and viral infection: the immaturity of the infant immune system alters the outcome of viral infection, but at the same time, viral infection shapes the development of the infant immune system and its future responses. Finally, both the virus and the immune response contribute to damage to the lungs and subsequent disease, and therefore, any prevention or treatment needs to address both of these factors.
从全球范围来看,呼吸道病毒感染是导致发病和死亡的主要原因。特别是婴儿期,疾病易感性和严重程度都有所增加。生命早期的病毒感染会导致急性疾病,并可能与以后生活中喘息和哮喘的发展有关。最常检测到的病毒是呼吸道合胞病毒(RSV)、鼻病毒(RV)和流感病毒。在这篇综述中,我们探讨了从流行病学和病毒学到临床影响和免疫学的全貌。有三个突出的方面。第一个是相似程度:尽管感染的病毒各不相同,但临床结果、病毒逃避策略、免疫反应和长期后果都有许多共同特征。第二个是婴儿免疫系统和病毒感染之间的相互作用:婴儿免疫系统的不成熟改变了病毒感染的结果,但同时,病毒感染也塑造了婴儿免疫系统的发育及其未来的反应。最后,病毒和免疫反应都会导致肺部损伤和随后的疾病,因此,任何预防或治疗措施都需要同时解决这两个因素。